Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA)

Background:  Mivacurium is hydrolyzed by plasma cholinesterase (pChe). The purpose of this study was to evaluate the pharmacodynamics and the pharmacokinetics of the three isomers of mivacurium in patients phenotypically heterozygous for the usual and the atypical pChe variant (UA).

[1]  L. Skovgaard,et al.  Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients , 2002, Acta anaesthesiologica Scandinavica.

[2]  L. Skovgaard,et al.  Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients , 2002, Acta anaesthesiologica Scandinavica.

[3]  L. Skovgaard,et al.  Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP) , 2000, Acta anaesthesiologica Scandinavica.

[4]  N. Goudsouzian,et al.  Prolonged mivacurium infusion in young and elderly adults. , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[5]  R. Farinotti,et al.  A855 A pharmacokinetic and dynamic study of mivacurium infusion in elderly patients , 1997 .

[6]  S. Rasmussen,et al.  A854 THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIVACURIUM IN PATIENTS HOMOZYGOUS FOR THE ATYPICAL PLASMA CHOLINESTERASE GENE , 1997 .

[7]  F. Donati,et al.  Pharmacokinetics of Mivacurium Isomers and Their Metabolites in Healthy Volunteers after Intravenous Bolus Administration , 1997, Anesthesiology.

[8]  L. Skovgaard,et al.  Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents , 1996, Acta anaesthesiologica Scandinavica.

[9]  L. Skovgaard,et al.  Dose‐response relationship for mivacurium inpatients with phenotypically abnormal plasma cholinesterase activity , 1995, Acta anaesthesiologica Scandinavica.

[10]  J. Hunter,et al.  Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. , 1995, British journal of anaesthesia.

[11]  L. Skovgaard,et al.  Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis , 1995, Acta anaesthesiologica Scandinavica.

[12]  T. Sharpe,et al.  Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. , 1994, British journal of anaesthesia.

[13]  J. Hunter,et al.  Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. , 1994, British journal of anaesthesia.

[14]  C. Lien,et al.  The Phamtacokinetics and Pharmacodynamics of the Stereoisomers of Mivacurium in Patients Receiving Nitrous Oxide/Opioid/Barbiturate Anesthesia , 1994, Anesthesiology.

[15]  L. Skovgaard,et al.  Mivacurium‐induced neuromuscular blockade in patients with atypical plasma cholinesterase , 1993, Acta anaesthesiologica Scandinavica.

[16]  W. Buzello,et al.  Mivacurium: Dose‐Response Relationship and Administration by Repeated Injection or Infusion , 1992, Anesthesia and analgesia.

[17]  T. Heier,et al.  The dose-response relationship of mivacurium chloride in humans during nitrous oxide-fentanyl or nitrous oxide-enflurane anesthesia. , 1989, Anesthesiology.

[18]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[19]  L. Skovgaard,et al.  Dose‐response Curves for Vecuronium during Halothane and Neurolept Anaesthesia: Single Bolus versus Cumulative Method , 1985, Acta anaesthesiologica Scandinavica.

[20]  J. Viby-Mogensen,et al.  A Danish Cholinesterase Research Unit , 1977, Acta anaesthesiologica Scandinavica.